ABIONYX PHARMA: cashflow_investing
| Value | {"amount": 1338000.0, "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | ABIONYX PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T00:57:07.391012+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/5ab6bcf1-6971-491c-bd8a-967ccdbdaf70
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:969500785J7VIC5YPC96:2022-12-31Retrieved: 2026-08-24T00:57:07.391012+02:00
Raw response sha256:
6a2b623de4454d15f9b99020bed4c4d5…Cite as: FACTANKER, https://factanker.com/fact/5ab6bcf1-6971-491c-bd8a-967ccdbdaf70
History
- no predecessors — first report